Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma
- PMID: 31901550
- DOI: 10.1016/j.biopha.2019.109780
Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma
Abstract
FAM83A is part of an 8-member protein family of unknown function and is reported to be a cancer-promoting and treatment-resistance factor in several cancers. However, its role in hepatocellular carcinoma (HCC) remains unclear. Analysis of the Cancer Genome Atlas (TCGA) showed that FAM83A mRNA expression is upregulated in HCC, as are the protein expression levels in both HCC cell lines and tissues. Clinical data have demonstrated that high FAM83A expression is positively correlated with poor progression-free survival time, thus suggesting its cancer-promoting potential. Functional analyses showed that FAM83A overexpression promoted HCC cell migration and invasion in vitro and suppressed sorafenib sensitivity. Inhibiting FAM83A reversed these results. A pulmonary metastasis model further confirmed that FAM83A promoted HCC cell metastasis in vivo. Mechanistic analyses indicated that FAM83A activated the PI3K/AKT signaling pathway, its downstream c-JUN protein, and epithelial-to-mesenchymal transition (EMT)-related protein levels, including downregulation of E-cadherin and upregulation of Vimentin and N-cadherin. Interestingly, c-JUN induced FAM83A expression by directly binding to its promoter region and thus forming a positive-feedback loop for FAM83A/PI3K/AKT/c-JUN. In conclusion, we demonstrated that FAM83A, as a cancer-metastasis promoter, accelerates migration, invasion and metastasis by activating the PI3K/AKT/c-JUN pathway and inducing its self-expression via feedback, thus forming a FAM83A/PI3K/AKT/c-JUN positive-feedback loop to activate EMT signaling and finally promote HCC migration, invasion and metastasis.
Keywords: EMT; FAM83A; HCC; Metastasis; PI3K/AKT.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no potential conflicts of interest.
Similar articles
-
TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.Oncol Res. 2017 Sep 21;25(8):1329-1340. doi: 10.3727/096504017X14876227286564. Epub 2017 Mar 2. Oncol Res. 2017. PMID: 28256185 Free PMC article.
-
Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.Oncol Rep. 2014 Oct;32(4):1465-72. doi: 10.3892/or.2014.3352. Epub 2014 Jul 23. Oncol Rep. 2014. PMID: 25070581
-
miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7. Biomed Pharmacother. 2018. PMID: 29864952
-
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.Pharmacol Res. 2023 Jan;187:106553. doi: 10.1016/j.phrs.2022.106553. Epub 2022 Nov 15. Pharmacol Res. 2023. PMID: 36400343 Review.
-
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.Int J Mol Sci. 2023 Jan 31;24(3):2652. doi: 10.3390/ijms24032652. Int J Mol Sci. 2023. PMID: 36768977 Free PMC article. Review.
Cited by
-
Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature.Sci Rep. 2023 Oct 16;13(1):17577. doi: 10.1038/s41598-023-43036-7. Sci Rep. 2023. PMID: 37845218 Free PMC article.
-
Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.J Cancer. 2023 Jun 26;14(10):1888-1903. doi: 10.7150/jca.83420. eCollection 2023. J Cancer. 2023. PMID: 37476189 Free PMC article. Review.
-
ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer.Front Endocrinol (Lausanne). 2023 Mar 31;14:1093042. doi: 10.3389/fendo.2023.1093042. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37065746 Free PMC article.
-
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.Adv Sci (Weinh). 2023 May;10(14):e2203423. doi: 10.1002/advs.202203423. Epub 2023 Mar 16. Adv Sci (Weinh). 2023. PMID: 36929633 Free PMC article.
-
B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.Signal Transduct Target Ther. 2023 Feb 17;8(1):66. doi: 10.1038/s41392-022-01268-5. Signal Transduct Target Ther. 2023. PMID: 36797256 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
